The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
 
Chrysiida Chatzigiannidou-Florou
No Relationships to Disclose
 
Aikaterini Tsantikidi
No Relationships to Disclose
 
Eleni Thanou
No Relationships to Disclose
 
Eirini Papadopoulou
No Relationships to Disclose
 
Nektarios Alevizopoulos
No Relationships to Disclose
 
Athanasios Karampeazis
Honoraria - Astellas Pharma; Genesis Pharma; MSD Oncology
Consulting or Advisory Role - Faran A.E.B.E, Greece
Travel, Accommodations, Expenses - Astellas Pharma; Galenica; Galenica; Innovis Pharma; Integris; Pfizer; Pfizer
 
Ilias Athanasiadis
Employment - MITERA; SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Leadership - MITERA; SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Stock and Other Ownership Interests - SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Honoraria - Amgen; Astellas Pharma; AstraZeneca; BMSi; Genesis Pharma; Gilead Sciences Hellas; GlaxoSmithKline; INTEGRIS PHARMA; Ipsen; JANSSEN CILAG; LEO Pharma; Lilly; MSD Oncology; Novartis; Pfizer Hellas; PHARMABIDE; Pierre Fabre Hellas; QUALITIS EPE; Roche; SERVIER; SPECIFAR
Consulting or Advisory Role - AMGEN; AstraZeneca; Genesis Pharmaceuticals; GILEAD SCIENCES HELLAS; GLAXOSMITHKLINE; INTEGRIS PHARMA; JANSSEN CILAG; LILLY; MERCH SHARP & DOHME; MSD Oncology; NOVARTIS; Pfizer; PHARMABIDE; Pierre Fabre Hellas; QUALITIS; ROCHE; SERVIER; SPECIFAR
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer Hellas
(OPTIONAL) Uncompensated Relationships - HECOG
 
Giannis Mountzios
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca/Greece; BMS GmbH & Co. KG; MSD; Novartis; Roche; Takeda
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; BMS GmbH & Co. KG; Demo Pharmaceutical; Ipsen; MSD; Novartis; Roche
 
Stefanos Dimoudis
No Relationships to Disclose
 
Panagiotis Vlachostergios
No Relationships to Disclose
 
Maria Kaparelou
No Relationships to Disclose
 
Nikolaos Tsoulos
Employment - GeneKor
Leadership - GeneKor
Stock and Other Ownership Interests - GeneKor
Consulting or Advisory Role - GeneKor
Travel, Accommodations, Expenses - GeneKor
 
Ilhan Hacibekiroglu
No Relationships to Disclose
 
Ilker Okten
No Relationships to Disclose
 
Mircea Dediu
No Relationships to Disclose
 
Georges El Hachem
No Relationships to Disclose
 
Hady Ghanem
No Relationships to Disclose
 
Syed Karim
No Relationships to Disclose
 
George Nasioulas
No Relationships to Disclose